Skip to main content
OpenTrials
Completed

NCT Number: NCT02334033

Cystatin C and Uncontrolled Hypertension

Hypertension is an underdiagnosed and undertreated disease in real-life. Blood pressure and kidney functions are known to be closely related. Increased serum level of Cystatin C, a sensitive biomarker for renal function, seems to predict adverse cardiovascular events. The investigators aimed to evaluate the predictive value of serum Cystatin C for control of hypertension in a community-based study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Ankara University School Of Medicine, Department of Cardiology

Ankara, 06230, Turkey (Türkiye)

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Individuals who accept to participate to the survey
  • > 18 years

Exclusion criteria

  • Individuals who are not able to complete the questionnaire
  • Individuals who didn't give informed consent

Treatment and study plan

other

Other

Primary outcomes

  1. The prevalence of uncontrolled hypertension

    Time frame: At subject enrollment

    The outcome measures will be obtained at the time of enrollment

Secondary outcomes

  1. The value of cystatin C to determine uncontrolled hypertension

    Time frame: At subject enrollment

    The outcome measures will be obtained at the time of enrollment

Sponsors and collaborators

Lead sponsor

Ankara University

Other

Registry information

Important dates

Study start
2014
Primary completion
2015
Study completion
2015
First posted
Jan 8, 2015
Registry last updated
Jan 27, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.